Activation of mGluRI in neutrophils promotes the adherence of neutrophils to endothelial cells.
- Author:
Xue-Yun LIU
1
;
Yong LIU
;
Jin-Feng LI
;
Shao-Jie YUE
;
Li SHEN
;
Chen LI
;
Jian-Zhong HAN
;
Jian-Ping XU
;
Dan-Dan FENG
;
Hui-Jun LIU
;
Zi-Qiang LUO
Author Information
1. Department of Physiology, Xiangya School of Medicine, Central South University, Changsha, China.
- Publication Type:Journal Article
- MeSH:
Benzoates;
pharmacology;
CD11a Antigen;
metabolism;
Cell Adhesion;
Endothelial Cells;
cytology;
Glycine;
analogs & derivatives;
pharmacology;
Human Umbilical Vein Endothelial Cells;
Humans;
Neutrophils;
cytology;
Receptor, Metabotropic Glutamate 5;
metabolism;
Receptors, Metabotropic Glutamate;
metabolism;
Resorcinols;
pharmacology
- From:
Acta Physiologica Sinica
2010;62(3):219-224
- CountryChina
- Language:Chinese
-
Abstract:
L-glutamate (Glu) is an excitatory neurotransmitter in the mammalian central nervous system. Relatively much attention has been paid to functional expression of Glu signaling molecules in peripheral tissues very recently. The present study tested the hypothesis that the activation of group I metabotropic glutamate receptor (mGluRI) in neutrophils stimulated neutrophils adherence to endothelial cells by increasing the surface expression of certain adhesion molecules. Peripheral blood was obtained by venipuncture from healthy donors, and the neutrophils were isolated by Ficoll-Hypaque gradient centrifugation. Neutrophils floating into DMEM/F12 culture medium containing 10% fetal bovine serum were then used immediately. Immunocytochemistry and real-time quantitative RT-PCR were used to detect the expression of mGluRI (mGluR1 and mGluR5) in neutrophils. The adherence of neutrophils to cultured human normal umbilical vein endothelial cells (HUVE-12) was measured by the colorimetric method. Cell surface expression of adhesion molecule CD11a in the neutrophils was determined by flow cytometry. Immunocytochemistry and real-time quantitative RT-PCR showed that mGluR1 and mGluR5 were constitutively expressed in neutrophils. Application of mGluRI agonist S-3,5-dihydroxyphenylglycine (S-DHPG) (1x10(-8)-1x10(-6) mol/L) showed a dose-dependent stimulatory effect on the adherence of neutrophils to HUVE-12 (P<0.05 or P<0.01), with a maximum effect at 1x10(-6) mol/L (P<0.01). Incubations as short as 30 min were sufficient to induce increased adherence after the beginning of S-DHPG treatment. Following time extension (0.5-5 h), S-DHPG (1x10(-6) mol/L) increased the rate of neutrophils adhesion to HUVE-12 with a maximum effect at 0.5 h (P<0.01). However, a time-dependent effect of S-DHPG on the rate of neutrophils adhesion to HUVE-12 was not observed during the experimental period. 1x10(-6) mol/L of S-DHPG also induced an increased surface expression of adhesion molecule CD11a (P<0.01) when neutrophils were preincubated with 1x10(-6) mol/L of S-DHPG for 1 h. Furthermore, the specific mGluRI antagonist (RS)-alpha-methyl-4-carboxyphenylglycine ((+/-)-MCPG, 0.5 mmol/L) significantly abolished the stimulatory effect of S-DHPG (1x10(-6) mol/L) on the adherence of neutrophils to HUVE-12 (P<0.01). These results suggest that the activation of mGluRI in neutrophils results in increased adhesion molecule CD11a expression and thereby promotes the adherence of neutrophils to endothelial cells.
